Global Antiretroviral Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Antiretroviral Agent market size was valued at USD 49750 million in 2023 and is forecast to a readjusted size of USD 62660 million by 2030 with a CAGR of 3.3% during review period.

The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand.  In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Antiretroviral Agent industry chain, the market status of Hospital Pharmacies (Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors), Retail Pharmacies (Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiretroviral Agent.

Regionally, the report analyzes the Antiretroviral Agent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiretroviral Agent market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Antiretroviral Agent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiretroviral Agent industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiretroviral Agent market.

Regional Analysis: The report involves examining the Antiretroviral Agent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiretroviral Agent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Antiretroviral Agent:
Company Analysis: Report covers individual Antiretroviral Agent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiretroviral Agent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).

Technology Analysis: Report covers specific technologies relevant to Antiretroviral Agent. It assesses the current state, advancements, and potential future developments in Antiretroviral Agent areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiretroviral Agent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Antiretroviral Agent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Nucleoside Reverse Transcriptase Inhibitors
    Protease Inhibitors
    HIV Integrase Strand Transfer Inhibitors
    Non-Nucleoside Reverse Transcriptase Inhibitors
    Entry Inhibitors—CCR5 Co-Receptor Antagonist
    Fusion Inhibitors
    Others

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

Major players covered
    ViiV Healthcare
    Gilead Sciences
    GlaxoSmithKline
    Merck Sharp and Dohme
    Bristol-Myers Squibb
    Janssen Pharmaceuticals
    Pfizer
    Boehringer Ingelheim
    AbbVie
    Genentech
    Mylan

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiretroviral Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antiretroviral Agent, with price, sales, revenue and global market share of Antiretroviral Agent from 2019 to 2024.
Chapter 3, the Antiretroviral Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiretroviral Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antiretroviral Agent market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antiretroviral Agent.
Chapter 14 and 15, to describe Antiretroviral Agent sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Antiretroviral Agent
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Antiretroviral Agent Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Nucleoside Reverse Transcriptase Inhibitors
        1.3.3 Protease Inhibitors
        1.3.4 HIV Integrase Strand Transfer Inhibitors
        1.3.5 Non-Nucleoside Reverse Transcriptase Inhibitors
        1.3.6 Entry Inhibitors—CCR5 Co-Receptor Antagonist
        1.3.7 Fusion Inhibitors
        1.3.8 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Antiretroviral Agent Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
        1.4.5 Others
    1.5 Global Antiretroviral Agent Market Size & Forecast
        1.5.1 Global Antiretroviral Agent Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Antiretroviral Agent Sales Quantity (2019-2030)
        1.5.3 Global Antiretroviral Agent Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 ViiV Healthcare
        2.1.1 ViiV Healthcare Details
        2.1.2 ViiV Healthcare Major Business
        2.1.3 ViiV Healthcare Antiretroviral Agent Product and Services
        2.1.4 ViiV Healthcare Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 ViiV Healthcare Recent Developments/Updates
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Antiretroviral Agent Product and Services
        2.2.4 Gilead Sciences Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Gilead Sciences Recent Developments/Updates
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Antiretroviral Agent Product and Services
        2.3.4 GlaxoSmithKline Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 GlaxoSmithKline Recent Developments/Updates
    2.4 Merck Sharp and Dohme
        2.4.1 Merck Sharp and Dohme Details
        2.4.2 Merck Sharp and Dohme Major Business
        2.4.3 Merck Sharp and Dohme Antiretroviral Agent Product and Services
        2.4.4 Merck Sharp and Dohme Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Merck Sharp and Dohme Recent Developments/Updates
    2.5 Bristol-Myers Squibb
        2.5.1 Bristol-Myers Squibb Details
        2.5.2 Bristol-Myers Squibb Major Business
        2.5.3 Bristol-Myers Squibb Antiretroviral Agent Product and Services
        2.5.4 Bristol-Myers Squibb Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Bristol-Myers Squibb Recent Developments/Updates
    2.6 Janssen Pharmaceuticals
        2.6.1 Janssen Pharmaceuticals Details
        2.6.2 Janssen Pharmaceuticals Major Business
        2.6.3 Janssen Pharmaceuticals Antiretroviral Agent Product and Services
        2.6.4 Janssen Pharmaceuticals Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Janssen Pharmaceuticals Recent Developments/Updates
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Antiretroviral Agent Product and Services
        2.7.4 Pfizer Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Pfizer Recent Developments/Updates
    2.8 Boehringer Ingelheim
        2.8.1 Boehringer Ingelheim Details
        2.8.2 Boehringer Ingelheim Major Business
        2.8.3 Boehringer Ingelheim Antiretroviral Agent Product and Services
        2.8.4 Boehringer Ingelheim Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Boehringer Ingelheim Recent Developments/Updates
    2.9 AbbVie
        2.9.1 AbbVie Details
        2.9.2 AbbVie Major Business
        2.9.3 AbbVie Antiretroviral Agent Product and Services
        2.9.4 AbbVie Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 AbbVie Recent Developments/Updates
    2.10 Genentech
        2.10.1 Genentech Details
        2.10.2 Genentech Major Business
        2.10.3 Genentech Antiretroviral Agent Product and Services
        2.10.4 Genentech Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Genentech Recent Developments/Updates
    2.11 Mylan
        2.11.1 Mylan Details
        2.11.2 Mylan Major Business
        2.11.3 Mylan Antiretroviral Agent Product and Services
        2.11.4 Mylan Antiretroviral Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Mylan Recent Developments/Updates

3 Competitive Environment: Antiretroviral Agent by Manufacturer
    3.1 Global Antiretroviral Agent Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Antiretroviral Agent Revenue by Manufacturer (2019-2024)
    3.3 Global Antiretroviral Agent Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Antiretroviral Agent by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Antiretroviral Agent Manufacturer Market Share in 2023
        3.4.2 Top 6 Antiretroviral Agent Manufacturer Market Share in 2023
    3.5 Antiretroviral Agent Market: Overall Company Footprint Analysis
        3.5.1 Antiretroviral Agent Market: Region Footprint
        3.5.2 Antiretroviral Agent Market: Company Product Type Footprint
        3.5.3 Antiretroviral Agent Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Antiretroviral Agent Market Size by Region
        4.1.1 Global Antiretroviral Agent Sales Quantity by Region (2019-2030)
        4.1.2 Global Antiretroviral Agent Consumption Value by Region (2019-2030)
        4.1.3 Global Antiretroviral Agent Average Price by Region (2019-2030)
    4.2 North America Antiretroviral Agent Consumption Value (2019-2030)
    4.3 Europe Antiretroviral Agent Consumption Value (2019-2030)
    4.4 Asia-Pacific Antiretroviral Agent Consumption Value (2019-2030)
    4.5 South America Antiretroviral Agent Consumption Value (2019-2030)
    4.6 Middle East and Africa Antiretroviral Agent Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Antiretroviral Agent Sales Quantity by Type (2019-2030)
    5.2 Global Antiretroviral Agent Consumption Value by Type (2019-2030)
    5.3 Global Antiretroviral Agent Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Antiretroviral Agent Sales Quantity by Application (2019-2030)
    6.2 Global Antiretroviral Agent Consumption Value by Application (2019-2030)
    6.3 Global Antiretroviral Agent Average Price by Application (2019-2030)

7 North America
    7.1 North America Antiretroviral Agent Sales Quantity by Type (2019-2030)
    7.2 North America Antiretroviral Agent Sales Quantity by Application (2019-2030)
    7.3 North America Antiretroviral Agent Market Size by Country
        7.3.1 North America Antiretroviral Agent Sales Quantity by Country (2019-2030)
        7.3.2 North America Antiretroviral Agent Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Antiretroviral Agent Sales Quantity by Type (2019-2030)
    8.2 Europe Antiretroviral Agent Sales Quantity by Application (2019-2030)
    8.3 Europe Antiretroviral Agent Market Size by Country
        8.3.1 Europe Antiretroviral Agent Sales Quantity by Country (2019-2030)
        8.3.2 Europe Antiretroviral Agent Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Antiretroviral Agent Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Antiretroviral Agent Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Antiretroviral Agent Market Size by Region
        9.3.1 Asia-Pacific Antiretroviral Agent Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Antiretroviral Agent Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Antiretroviral Agent Sales Quantity by Type (2019-2030)
    10.2 South America Antiretroviral Agent Sales Quantity by Application (2019-2030)
    10.3 South America Antiretroviral Agent Market Size by Country
        10.3.1 South America Antiretroviral Agent Sales Quantity by Country (2019-2030)
        10.3.2 South America Antiretroviral Agent Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Antiretroviral Agent Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Antiretroviral Agent Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Antiretroviral Agent Market Size by Country
        11.3.1 Middle East & Africa Antiretroviral Agent Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Antiretroviral Agent Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Antiretroviral Agent Market Drivers
    12.2 Antiretroviral Agent Market Restraints
    12.3 Antiretroviral Agent Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Antiretroviral Agent and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Antiretroviral Agent
    13.3 Antiretroviral Agent Production Process
    13.4 Antiretroviral Agent Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Antiretroviral Agent Typical Distributors
    14.3 Antiretroviral Agent Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Antiretroviral Agent Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Antiretroviral Agent Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
    Table 4. ViiV Healthcare Major Business
    Table 5. ViiV Healthcare Antiretroviral Agent Product and Services
    Table 6. ViiV Healthcare Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. ViiV Healthcare Recent Developments/Updates
    Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 9. Gilead Sciences Major Business
    Table 10. Gilead Sciences Antiretroviral Agent Product and Services
    Table 11. Gilead Sciences Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Gilead Sciences Recent Developments/Updates
    Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 14. GlaxoSmithKline Major Business
    Table 15. GlaxoSmithKline Antiretroviral Agent Product and Services
    Table 16. GlaxoSmithKline Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. GlaxoSmithKline Recent Developments/Updates
    Table 18. Merck Sharp and Dohme Basic Information, Manufacturing Base and Competitors
    Table 19. Merck Sharp and Dohme Major Business
    Table 20. Merck Sharp and Dohme Antiretroviral Agent Product and Services
    Table 21. Merck Sharp and Dohme Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Merck Sharp and Dohme Recent Developments/Updates
    Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 24. Bristol-Myers Squibb Major Business
    Table 25. Bristol-Myers Squibb Antiretroviral Agent Product and Services
    Table 26. Bristol-Myers Squibb Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Bristol-Myers Squibb Recent Developments/Updates
    Table 28. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 29. Janssen Pharmaceuticals Major Business
    Table 30. Janssen Pharmaceuticals Antiretroviral Agent Product and Services
    Table 31. Janssen Pharmaceuticals Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Janssen Pharmaceuticals Recent Developments/Updates
    Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 34. Pfizer Major Business
    Table 35. Pfizer Antiretroviral Agent Product and Services
    Table 36. Pfizer Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Pfizer Recent Developments/Updates
    Table 38. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 39. Boehringer Ingelheim Major Business
    Table 40. Boehringer Ingelheim Antiretroviral Agent Product and Services
    Table 41. Boehringer Ingelheim Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Boehringer Ingelheim Recent Developments/Updates
    Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 44. AbbVie Major Business
    Table 45. AbbVie Antiretroviral Agent Product and Services
    Table 46. AbbVie Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. AbbVie Recent Developments/Updates
    Table 48. Genentech Basic Information, Manufacturing Base and Competitors
    Table 49. Genentech Major Business
    Table 50. Genentech Antiretroviral Agent Product and Services
    Table 51. Genentech Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Genentech Recent Developments/Updates
    Table 53. Mylan Basic Information, Manufacturing Base and Competitors
    Table 54. Mylan Major Business
    Table 55. Mylan Antiretroviral Agent Product and Services
    Table 56. Mylan Antiretroviral Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Mylan Recent Developments/Updates
    Table 58. Global Antiretroviral Agent Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 59. Global Antiretroviral Agent Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 60. Global Antiretroviral Agent Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 61. Market Position of Manufacturers in Antiretroviral Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 62. Head Office and Antiretroviral Agent Production Site of Key Manufacturer
    Table 63. Antiretroviral Agent Market: Company Product Type Footprint
    Table 64. Antiretroviral Agent Market: Company Product Application Footprint
    Table 65. Antiretroviral Agent New Market Entrants and Barriers to Market Entry
    Table 66. Antiretroviral Agent Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Antiretroviral Agent Sales Quantity by Region (2019-2024) & (K Units)
    Table 68. Global Antiretroviral Agent Sales Quantity by Region (2025-2030) & (K Units)
    Table 69. Global Antiretroviral Agent Consumption Value by Region (2019-2024) & (USD Million)
    Table 70. Global Antiretroviral Agent Consumption Value by Region (2025-2030) & (USD Million)
    Table 71. Global Antiretroviral Agent Average Price by Region (2019-2024) & (US$/Unit)
    Table 72. Global Antiretroviral Agent Average Price by Region (2025-2030) & (US$/Unit)
    Table 73. Global Antiretroviral Agent Sales Quantity by Type (2019-2024) & (K Units)
    Table 74. Global Antiretroviral Agent Sales Quantity by Type (2025-2030) & (K Units)
    Table 75. Global Antiretroviral Agent Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Global Antiretroviral Agent Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Global Antiretroviral Agent Average Price by Type (2019-2024) & (US$/Unit)
    Table 78. Global Antiretroviral Agent Average Price by Type (2025-2030) & (US$/Unit)
    Table 79. Global Antiretroviral Agent Sales Quantity by Application (2019-2024) & (K Units)
    Table 80. Global Antiretroviral Agent Sales Quantity by Application (2025-2030) & (K Units)
    Table 81. Global Antiretroviral Agent Consumption Value by Application (2019-2024) & (USD Million)
    Table 82. Global Antiretroviral Agent Consumption Value by Application (2025-2030) & (USD Million)
    Table 83. Global Antiretroviral Agent Average Price by Application (2019-2024) & (US$/Unit)
    Table 84. Global Antiretroviral Agent Average Price by Application (2025-2030) & (US$/Unit)
    Table 85. North America Antiretroviral Agent Sales Quantity by Type (2019-2024) & (K Units)
    Table 86. North America Antiretroviral Agent Sales Quantity by Type (2025-2030) & (K Units)
    Table 87. North America Antiretroviral Agent Sales Quantity by Application (2019-2024) & (K Units)
    Table 88. North America Antiretroviral Agent Sales Quantity by Application (2025-2030) & (K Units)
    Table 89. North America Antiretroviral Agent Sales Quantity by Country (2019-2024) & (K Units)
    Table 90. North America Antiretroviral Agent Sales Quantity by Country (2025-2030) & (K Units)
    Table 91. North America Antiretroviral Agent Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. North America Antiretroviral Agent Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Europe Antiretroviral Agent Sales Quantity by Type (2019-2024) & (K Units)
    Table 94. Europe Antiretroviral Agent Sales Quantity by Type (2025-2030) & (K Units)
    Table 95. Europe Antiretroviral Agent Sales Quantity by Application (2019-2024) & (K Units)
    Table 96. Europe Antiretroviral Agent Sales Quantity by Application (2025-2030) & (K Units)
    Table 97. Europe Antiretroviral Agent Sales Quantity by Country (2019-2024) & (K Units)
    Table 98. Europe Antiretroviral Agent Sales Quantity by Country (2025-2030) & (K Units)
    Table 99. Europe Antiretroviral Agent Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Antiretroviral Agent Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Antiretroviral Agent Sales Quantity by Type (2019-2024) & (K Units)
    Table 102. Asia-Pacific Antiretroviral Agent Sales Quantity by Type (2025-2030) & (K Units)
    Table 103. Asia-Pacific Antiretroviral Agent Sales Quantity by Application (2019-2024) & (K Units)
    Table 104. Asia-Pacific Antiretroviral Agent Sales Quantity by Application (2025-2030) & (K Units)
    Table 105. Asia-Pacific Antiretroviral Agent Sales Quantity by Region (2019-2024) & (K Units)
    Table 106. Asia-Pacific Antiretroviral Agent Sales Quantity by Region (2025-2030) & (K Units)
    Table 107. Asia-Pacific Antiretroviral Agent Consumption Value by Region (2019-2024) & (USD Million)
    Table 108. Asia-Pacific Antiretroviral Agent Consumption Value by Region (2025-2030) & (USD Million)
    Table 109. South America Antiretroviral Agent Sales Quantity by Type (2019-2024) & (K Units)
    Table 110. South America Antiretroviral Agent Sales Quantity by Type (2025-2030) & (K Units)
    Table 111. South America Antiretroviral Agent Sales Quantity by Application (2019-2024) & (K Units)
    Table 112. South America Antiretroviral Agent Sales Quantity by Application (2025-2030) & (K Units)
    Table 113. South America Antiretroviral Agent Sales Quantity by Country (2019-2024) & (K Units)
    Table 114. South America Antiretroviral Agent Sales Quantity by Country (2025-2030) & (K Units)
    Table 115. South America Antiretroviral Agent Consumption Value by Country (2019-2024) & (USD Million)
    Table 116. South America Antiretroviral Agent Consumption Value by Country (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Antiretroviral Agent Sales Quantity by Type (2019-2024) & (K Units)
    Table 118. Middle East & Africa Antiretroviral Agent Sales Quantity by Type (2025-2030) & (K Units)
    Table 119. Middle East & Africa Antiretroviral Agent Sales Quantity by Application (2019-2024) & (K Units)
    Table 120. Middle East & Africa Antiretroviral Agent Sales Quantity by Application (2025-2030) & (K Units)
    Table 121. Middle East & Africa Antiretroviral Agent Sales Quantity by Region (2019-2024) & (K Units)
    Table 122. Middle East & Africa Antiretroviral Agent Sales Quantity by Region (2025-2030) & (K Units)
    Table 123. Middle East & Africa Antiretroviral Agent Consumption Value by Region (2019-2024) & (USD Million)
    Table 124. Middle East & Africa Antiretroviral Agent Consumption Value by Region (2025-2030) & (USD Million)
    Table 125. Antiretroviral Agent Raw Material
    Table 126. Key Manufacturers of Antiretroviral Agent Raw Materials
    Table 127. Antiretroviral Agent Typical Distributors
    Table 128. Antiretroviral Agent Typical Customers
List of Figures
    Figure 1. Antiretroviral Agent Picture
    Figure 2. Global Antiretroviral Agent Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Antiretroviral Agent Consumption Value Market Share by Type in 2023
    Figure 4. Nucleoside Reverse Transcriptase Inhibitors Examples
    Figure 5. Protease Inhibitors Examples
    Figure 6. HIV Integrase Strand Transfer Inhibitors Examples
    Figure 7. Non-Nucleoside Reverse Transcriptase Inhibitors Examples
    Figure 8. Entry Inhibitors—CCR5 Co-Receptor Antagonist Examples
    Figure 9. Fusion Inhibitors Examples
    Figure 10. Others Examples
    Figure 11. Global Antiretroviral Agent Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 12. Global Antiretroviral Agent Consumption Value Market Share by Application in 2023
    Figure 13. Hospital Pharmacies Examples
    Figure 14. Retail Pharmacies Examples
    Figure 15. Online Pharmacies Examples
    Figure 16. Others Examples
    Figure 17. Global Antiretroviral Agent Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 18. Global Antiretroviral Agent Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 19. Global Antiretroviral Agent Sales Quantity (2019-2030) & (K Units)
    Figure 20. Global Antiretroviral Agent Average Price (2019-2030) & (US$/Unit)
    Figure 21. Global Antiretroviral Agent Sales Quantity Market Share by Manufacturer in 2023
    Figure 22. Global Antiretroviral Agent Consumption Value Market Share by Manufacturer in 2023
    Figure 23. Producer Shipments of Antiretroviral Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 24. Top 3 Antiretroviral Agent Manufacturer (Consumption Value) Market Share in 2023
    Figure 25. Top 6 Antiretroviral Agent Manufacturer (Consumption Value) Market Share in 2023
    Figure 26. Global Antiretroviral Agent Sales Quantity Market Share by Region (2019-2030)
    Figure 27. Global Antiretroviral Agent Consumption Value Market Share by Region (2019-2030)
    Figure 28. North America Antiretroviral Agent Consumption Value (2019-2030) & (USD Million)
    Figure 29. Europe Antiretroviral Agent Consumption Value (2019-2030) & (USD Million)
    Figure 30. Asia-Pacific Antiretroviral Agent Consumption Value (2019-2030) & (USD Million)
    Figure 31. South America Antiretroviral Agent Consumption Value (2019-2030) & (USD Million)
    Figure 32. Middle East & Africa Antiretroviral Agent Consumption Value (2019-2030) & (USD Million)
    Figure 33. Global Antiretroviral Agent Sales Quantity Market Share by Type (2019-2030)
    Figure 34. Global Antiretroviral Agent Consumption Value Market Share by Type (2019-2030)
    Figure 35. Global Antiretroviral Agent Average Price by Type (2019-2030) & (US$/Unit)
    Figure 36. Global Antiretroviral Agent Sales Quantity Market Share by Application (2019-2030)
    Figure 37. Global Antiretroviral Agent Consumption Value Market Share by Application (2019-2030)
    Figure 38. Global Antiretroviral Agent Average Price by Application (2019-2030) & (US$/Unit)
    Figure 39. North America Antiretroviral Agent Sales Quantity Market Share by Type (2019-2030)
    Figure 40. North America Antiretroviral Agent Sales Quantity Market Share by Application (2019-2030)
    Figure 41. North America Antiretroviral Agent Sales Quantity Market Share by Country (2019-2030)
    Figure 42. North America Antiretroviral Agent Consumption Value Market Share by Country (2019-2030)
    Figure 43. United States Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. Canada Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. Mexico Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Europe Antiretroviral Agent Sales Quantity Market Share by Type (2019-2030)
    Figure 47. Europe Antiretroviral Agent Sales Quantity Market Share by Application (2019-2030)
    Figure 48. Europe Antiretroviral Agent Sales Quantity Market Share by Country (2019-2030)
    Figure 49. Europe Antiretroviral Agent Consumption Value Market Share by Country (2019-2030)
    Figure 50. Germany Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. France Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. United Kingdom Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Russia Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Italy Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Asia-Pacific Antiretroviral Agent Sales Quantity Market Share by Type (2019-2030)
    Figure 56. Asia-Pacific Antiretroviral Agent Sales Quantity Market Share by Application (2019-2030)
    Figure 57. Asia-Pacific Antiretroviral Agent Sales Quantity Market Share by Region (2019-2030)
    Figure 58. Asia-Pacific Antiretroviral Agent Consumption Value Market Share by Region (2019-2030)
    Figure 59. China Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Japan Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Korea Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. India Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Southeast Asia Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Australia Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. South America Antiretroviral Agent Sales Quantity Market Share by Type (2019-2030)
    Figure 66. South America Antiretroviral Agent Sales Quantity Market Share by Application (2019-2030)
    Figure 67. South America Antiretroviral Agent Sales Quantity Market Share by Country (2019-2030)
    Figure 68. South America Antiretroviral Agent Consumption Value Market Share by Country (2019-2030)
    Figure 69. Brazil Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Argentina Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Middle East & Africa Antiretroviral Agent Sales Quantity Market Share by Type (2019-2030)
    Figure 72. Middle East & Africa Antiretroviral Agent Sales Quantity Market Share by Application (2019-2030)
    Figure 73. Middle East & Africa Antiretroviral Agent Sales Quantity Market Share by Region (2019-2030)
    Figure 74. Middle East & Africa Antiretroviral Agent Consumption Value Market Share by Region (2019-2030)
    Figure 75. Turkey Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. Egypt Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 77. Saudi Arabia Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 78. South Africa Antiretroviral Agent Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 79. Antiretroviral Agent Market Drivers
    Figure 80. Antiretroviral Agent Market Restraints
    Figure 81. Antiretroviral Agent Market Trends
    Figure 82. Porters Five Forces Analysis
    Figure 83. Manufacturing Cost Structure Analysis of Antiretroviral Agent in 2023
    Figure 84. Manufacturing Process Analysis of Antiretroviral Agent
    Figure 85. Antiretroviral Agent Industrial Chain
    Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 87. Direct Channel Pros & Cons
    Figure 88. Indirect Channel Pros & Cons
    Figure 89. Methodology
    Figure 90. Research Process and Data Source

Companies Mentioned

ViiV Healthcare
Gilead Sciences
GlaxoSmithKline
Merck Sharp and Dohme
Bristol-Myers Squibb
Janssen Pharmaceuticals
Pfizer
Boehringer Ingelheim
AbbVie
Genentech
Mylan